Climacteric Manuscript Submission

Instructions for authors

Submitted manuscripts will be processed by the following Editors:

Europe: Mr N. Panay, Queen Charlotte’s & Chelsea Hospital, Du Cane Road, London, W12 0HS, UK. Tel: 44 (0) 208 383 3513; Fax: 44 (0) 208 383 8065

Rest of the World: Dr A. Fenton, Unit B, 11 Caledonian Road, Edgeware, Christchurch 8143, New Zealand. Tel: +64 03 366 1925; Fax: +64 03 366 1926

Copyright

It is a condition of publication that the authors transfer the world copyright of their manuscripts to the International Menopause Society. This ensures full copyright protection and allows dissemination of the article, and the Journal, to the widest possible readership in print and electronic formats. All material should conform to the uniform requirements for manuscripts submitted to biomedical journals (Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. Ann Intern Med 1997;126:36–47). Authors submitting reports of randomized clinical trials should ensure that their report conforms with the CONSORT Statement (http://www.consort-statement.org; The Revised CONSORT Statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663–94). Authors will normally be entitled to publish any part of their paper elsewhere provided permission is requested and the usual acknowledgements are given. The assignment of the copyright will not affect subsisting patent rights or arrangements relating to them. Illustrations, tables or quotations from other publications are already copyrighted and can be reproduced only with written permission from the copyright owner. Written permission to use these should accompany the manuscript.

For further details and frequently asked questions on Informa UK Ltd’s policy on copyright and authors’ rights, click here.

Ethical review

The Editors and Publisher support the principles of the Declaration of Helsinki and expect that the authors of papers submitted to the Journal will have obtained ethical consent and followed those legal and regulatory requirements for human experimentation with drugs, including informed consent, according to procedures which apply in their institution and country.

Authority and responsibility

The intellectual content of the paper is the responsibility of the authors. The Editors and the Publisher accept no responsibility for opinions and statements of authors. While every effort will be made by the Editors and Publisher to avoid inaccurate and misleading data, they accept no liability whatsoever for the consequences of wrong information.

The authors agree to keep the Editors and Publisher fully and effectually indemnified against any liability or claims that may arise out of the publication of inaccurate and/or misleading data.

Submission of manuscripts

Articles will be published in the following classifications: Original research articles, Reviews, Invited Editorials, Short reports, Case reports, Book reviews, Commentaries and Letters to the Editors.

All submissions should be made online at Climacteric’s Manuscript Central. New users should first create an account. Once a user is logged onto the site, submissions should be made via the Author Center.

There are seven steps in the submission process:

Authors are requested to state the type of article (original article, review, etc.) and the title of the paper; they must also provide at this stage the abstract of their paper (this allows the Editors to review the Abstract quickly so that they can request relevant referees to review the paper). The abstract should be structured (divided, for example, into objectives, methods, results and conclusions) and should not exceed 250 words.
Authors are requested to list 3–8 key words for the manuscript.
Authors should clearly designate one author as correspondent to whom proofs will also be sent, and the full postal address, telephone number and e-mail address, where available, of this individual should be given. The names, affiliations and e-mail addresses of all co-authors should be provided.
The authors are asked to suggest the names of possible referees for their paper, giving full contact details.
Here, the authors may provide their covering letter to the Editors, explaining their submission, and are asked to answer questions on any previous submission, conflicts of interest, source of funding, copyright, etc.
In this very important step, authors are asked to upload the files for their manuscript. Authors should prepare and upload two versions of their manuscript. The first document, entitled ‘File not for review’, should contain the complete text, including title, authors, affiliations, abstract, correspondence address, key words and tables. The second document, entitled ‘Main document’, should be the same as the first document but all information identifying the authors (names, e-mail addresses, addresses and affiliations) should be removed, to allow this document to be sent anonymously to referees. It is preferable for the tables to be included in these two versions of the manuscript. If, however, the size of any table makes this inclusion difficult, it may be loaded as a separate file. Figures should be loaded as separate files.
In the last step, authors are requested to check all the data submitted before finally submitting the manuscript.

If authors experience any difficulty in following the submission process, they are invited to contact Susan Brown, Editorial Assistant (susanbrownpress@gmail.com) for assistance.

Preparation of manuscripts

Presentation: Manuscripts should be typed, double-spaced. Most standard PC or Mac word-processing software packages are acceptable, although we prefer Microsoft Word in a PC format. Papers should be structured into headed sections as follows: Title page, Abstract, Introduction, Methods, Results, Discussion, Acknowledgements and References. Each section should begin on a new page. Other subsection headings within the main headings may be used but should be limited.
The first page should include: title, first and last name of the authors and their affiliations, short title (no more than 20 letters), key words (3–8), and the address for correspondence, including telephone, facsimile and e-mail numbers.

Style: Authors whose native language is not English are requested to have their manuscript checked for linguistic correctness before submission. However, the Journal has a policy of encouraging the submission of good papers from authors whose first language is not English. Although articles must be written in English, authors will not be penalized on linguistic grounds by referees. In appropriate circumstances, the Editors will contribute to an improvement of the language used.

Abbreviations and symbols must be standard and SI units used throughout. Statistical analyses must explain the methods used. The use of footnotes is not permitted. Single quotation marks should be used. References to drugs should be by their approved, not proprietary names, and the source of any new or experimental preparations should be given. The Editors reserve the right to alter the manuscripts whenever necessary to make them conform to the stylistic and bibliographic conventions of the Journal.

Literature cited: References should be numbered consecutively throughout the text and cited as superscript numerals, e.g. 'Recent work on noise induced deafness21 has been...'.. They should be listed in full at the end of the article in Vancouver style, paying particular attention to the following:

Journal and book titles should be in italic.
The names and initials of all authors should be given (unless there are more than six, when only the first three should be given, followed by et al.)
Medical journal abbreviations follow Index Medicus usage.
Unpublished work, work in preparation or personal communications should not be used as references but merely mentioned in the text.
Authors must verify references against the original documents before submitting the manuscript.

References should be set out in the style of the following examples:

Journal article: Pike MC, Peters RK, Cozen W, et al. Estrogen–progestin replacement therapy and endometrial cancer. J Natl Cancer Inst 1997;89:1110–16

In press: (fill in current year): Evans GL, Turner RT. Tissue-selective actions of estrogen analogs. Bone 20–; in press

Book: Guyton AC. Circulatory Physiology: Cardiac Output and its Regulation. Philadelphia: Saunders, 1963:127–30

Article in an edited book: Meade TW. Epidemiology of thrombosis. In Loscalzo J, Schafer AI, eds. Thrombosis and Hemorrhage, Vol 2. Oxford: Blackwell Scientific, 1994:791–808

Published abstracts: Christiansen JS. Growth hormone, growth hormone secretagogues and aging. Presented at The First World Congress on the Aging Male, Geneva, February 1998. Aging Male 1998;1:6, Abstr 11

Acknowledgements: The scientific and material contributions of others to the work should be acknowledged, with their written permission. Any grant supports should be listed and permission for reproduction of published material acknowledged.

Declaration of interest: It is the policy of all Informa Healthcare to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE), http://www.icmje.org/index.html#conflict.

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers’ bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading ‘Conflict of interest’ and, where available, within the appropriate field on the journal’s Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.

If no conflict is declared, the following statement will be attached to all articles:

Conflict of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgments on conclusions drawn.

Source of funding: All sources of funding for research must be explicitly stated at the end of the manuscript. This information will also be published at the end of each paper.

Illustrations: Digital images are necessary and should be of high resolution. Any lettering must be large enough to permit a reduction in size. Illustrations must be saved individually and separately to the text. Please do not embed illustrations in the manuscript file.

Avoid the use of color and tints for purely esthetic reasons. Any figure submitted as a color original will appear in color in the journal’s online edition free of charge and can be downloaded. Color reproduction in the printed version of the journal may be considered at the Editors’ discretion but authors may be asked to contribute to the associated costs. Charges are: £500/US$1030 for the first color page and £250/US$515 for each color page after per article. (Color costs will be waived for invited Review Articles.)

The use of symbols in illustrations should be consistent with usage within the paper. Legends for illustrations should be collected together and presented on a separate manuscript page. Reference should be made specifically in the text to all figures. They should be numbered Figure 1, Figure 2, etc. All photographs should be of the highest quality possible, as reproduction reduces the quality. When photomicrographs are submitted, staining techniques should be stated and an internal scale marker included.

Files should be saved as one of the following formats: TIFF (tagged image file format), JPG, PostScript or EPS (encapsulated PostScript) and should contain all the necessary font information and the source file of the application (e.g. CorelDraw/Mac, CorelDraw/PC). If any of the illustrations submitted have been published elsewhere, written consent should be obtained from the copyright holder (usually the publisher) and the authors.

Tables: Each table should be submitted in the manuscript on a separate page, together with its caption. The following symbols should be used for foot notes: *, †, ‡, **. References should be made specifically in the text to all tables. They should be numbered Table 1, Table 2, etc. Tables should be simple and should not duplicate information in the text of the paper. If any of the tables submitted have been published elsewhere, written consent should be obtained from the copyright holder (usually the publisher) and the authors.

Proofs

The designated author will receive a copy of the proofs, which should be read carefully for errors. The corrected proof must be returned promptly. Authors will be asked to defray the expense of any major alterations to the proofs which are departures from the original manuscript.

Offprints and reprints

Offprints and reprints of articles published in this journal can be purchased once the article has been published online. Corresponding authors will receive free online access to their article through the Informaworld website (www.informaworld.com). Reprints of articles published in this journal can be purchased through Rightslink® when proofs are received. Copies of the Journal can be purchased at the authors’ preferential rate of £15.00/$25.00 per copy.

NIH Public Access Policy

In consideration of the National Institutes of Health (NIH) Public Access Policy, Informa Healthcare acknowledges that the broad and open dissemination of NIH-funded research results may benefit future scientific and medical research. Because we value the current and future contributions that our journals make to the scientific body of knowledge, we have made certain that our policies accommodate those authors who wish to submit to PubMed Central.
Informa Healthcare’s position with respect to public access to NIH-funded work published in Informa Healthcare journals is as follows:

Informa Healthcare authors may voluntarily submit their funded work to PubMed Central after a 12-month embargo period;
‘Funded work’ shall be defined as the final, peer-reviewed manuscript that is accepted by the Editor-in-Chief of the journal. This manuscript must not be altered by Publisher’s copyediting and typesetting services; and
This embargo period begins the day the work is published online at www.informaworld.com.